ATP1B3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.155790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.687600E-01
Normal-vs-Stage2
7.151800E-02
Normal-vs-Stage3
2.188400E-01
Normal-vs-Stage4
3.022500E-02
Stage1-vs-Stage2
2.868100E-02
Stage1-vs-Stage3
1.429990E-01
Stage1-vs-Stage4
6.662800E-03
Stage2-vs-Stage3
8.024000E-01
Stage2-vs-Stage4
2.254000E-01
Stage3-vs-Stage4
3.197000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.275560E-01
Normal-vs-AfricanAmerican
1.657380E-01
Normal-vs-Asian
9.888200E-02
Caucasian-vs-AfricanAmerican
6.426400E-01
Caucasian-vs-Asian
8.634200E-01
AfricanAmerican-vs-Asian
5.636000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.443790E-01
Normal-vs-Female
8.231700E-02
Male-vs-Female
8.623600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.502400E-01
Normal-vs-Age(41-60Yrs)
4.700000E-02
Normal-vs-Age(61-80Yrs)
1.581840E-01
Normal-vs-Age(81-100Yrs)
1.832430E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.284380E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.474000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.208600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.228100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.612800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.482600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.287200E-01
Normal-vs-Daily Drinker
2.555200E-01
Normal-vs-Weekly Drinker
2.660000E-02
Normal-vs-Occasional Drinker
1.386230E-01
Normal-vs-Social Drinker
1.620820E-01
Non Drinker-vs-Daily Drinker
1.238790E-01
Non Drinker-vs-Weekly Drinker
4.582900E-04
Non Drinker-vs-Occasional Drinker
2.024400E-02
Non Drinker-vs-Social Drinker
1.451560E-01
Daily Drinker-vs-Weekly Drinker
2.363800E-01
Daily Drinker-vs-Occasional Drinker
3.238200E-01
Daily Drinker-vs-Social Drinker
7.477000E-01
Weekly Drinker-vs-Occasional Drinker
9.149800E-01
Weekly Drinker-vs-Social Drinker
8.117600E-02
Occasional Drinker-vs-Social Drinker
2.009200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.720800E-01
Normal-vs-Grade 2
8.396000E-01
Normal-vs-Grade 3
5.560800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.16319999999381E-05
Grade 1-vs-Grade 3
9.426300E-04
Grade 1-vs-Grade 4
8.720800E-01
Grade 2-vs-Grade 3
6.464800E-01
Grade 2-vs-Grade 4
8.396000E-01
Grade 3-vs-Grade 4
5.560800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.827800E-01
Normal-vs-NonDiabetic
1.304650E-01
Diabetic-vs-NonDiabetic
5.109000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.660200E-02
Normal-vs-NoPancreatitis
1.479560E-01
Pancreatitis-vs-NoPancreatitis
9.165000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.088200E-01
Normal-vs-N1
7.624200E-02
N0-vs-N1
1.930960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.623600E-01
Normal-vs-TP53-NonMutant
7.792600E-01
TP53-Mutant-vs-TP53-NonMutant
2.44239999999118E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
